ZBIO
Zenas BioPharma Inc.
Company Overview
| Mkt Cap | $1.27B | Price | $31.25 |
| Volume | 569.69K | Change | +4.59% |
| P/E Ratio | -8.1 | Open | $29.93 |
| Revenue | $5.0M | Prev Close | $29.88 |
| Net Income | $-157.0M | 52W Range | $5.83 - $34.33 |
| Div Yield | N/A | Target | $35.50 |
| Overall | 66 | Value | 60 |
| Quality | -- | Technical | 72 |
No chart data available
Stock Overview
Updated DailyZenas BioPharma Inc. (ZBIO) is a leading diversified company in the business industry, currently trading at $31.25 with a market capitalization of $1.27 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ZBIO with a volume of 570K shares. The stock opened up 0.17% from yesterday's close of $29.88. Current analyst estimates project earnings of $-3.86 per share for this year, with next year targeting $-4.78.
ZBIO demonstrates strong technical indicators based on technical analysis. The company trades on the NGS exchange.
Key investment considerations for ZBIO include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 13.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 06:18 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZBIO | $31.25 | +4.6% | 569.69K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |